Gain Therapeutics, Inc.Gain Therapeutics, Inc.Gain Therapeutics, Inc.

Gain Therapeutics, Inc.

2,16USDR
−0,14−6,09%
A partir de hoje em 19:52 Horário Universal (UTC)
USD
Sem negociações
Veja nos super gráficos
Voltar

Lucro líquido diluído disponível para acionistas ordinários de Gain Therapeutics, Inc..

Dados anuais
2019
2020
2021
2022
2023
TTM
‪‪−24,00 M‬‬
‪‪−18,00 M‬‬
‪‪−12,00 M‬‬
‪‪−6,00 M‬‬
‪0,00‬
Período
Valor
Variação
Variação %
TTM
‪‪−21,37 M‬‬
+‪‪900,59 K‬‬
+‪4,04‬%
2023
‪‪−22,27 M‬‬
‪‪−4,68 M‬‬
‪−26,59‬%
2022
‪‪−17,59 M‬‬
‪‪−3,70 M‬‬
‪−26,64‬%
2021
‪‪−13,89 M‬‬
‪‪−10,31 M‬‬
‪−288,26‬%
2020
‪‪−3,58 M‬‬
‪‪−1,38 M‬‬
‪−63,11‬%
2019
‪‪−2,19 M‬‬
‪‪−1,09 M‬‬
‪−98,40‬%
Dados trimestrais
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−8,40 M‬‬
‪‪−6,30 M‬‬
‪‪−4,20 M‬‬
‪‪−2,10 M‬‬
‪0,00‬
Período
Valor
Variação
Variação %
Q3 '24
‪‪−4,49 M‬‬
+‪‪3,66 M‬‬
+‪44,91‬%
Q2 '24
‪‪−8,14 M‬‬
‪‪−4,13 M‬‬
‪−102,86‬%
Q1 '24
‪‪−4,01 M‬‬
+‪‪709,77 K‬‬
+‪15,02‬%
Q4 '23
‪‪−4,72 M‬‬
‪‪−5,71 K‬‬
‪−0,12‬%
Q3 '23
‪‪−4,72 M‬‬
+‪‪2,97 M‬‬
+‪38,63‬%
Q2 '23
‪‪−7,69 M‬‬
‪‪−2,55 M‬‬
‪−49,65‬%
Q1 '23
‪‪−5,14 M‬‬
‪‪−462,85 K‬‬
‪−9,90‬%
Q4 '22
‪‪−4,67 M‬‬
‪‪−116,26 K‬‬
‪−2,55‬%
Q3 '22
Q2 '22
Q1 '22
Q4 '21
Q3 '21
Q2 '21
Q1 '21
Q4 '20
Q3 '20